Morgan Juliette, McCarthy Kerrigan M, Gould Susan, Fan Ke, Arthington-Skaggs Beth, Iqbal Naureen, Stamey Karen, Hajjeh Rana A, Brandt Mary E
Mycotic Diseases Branch, Centers for Disease Control and Prevention, Atlanta, GA 30333, USA.
Clin Infect Dis. 2006 Oct 15;43(8):1077-80. doi: 10.1086/507897. Epub 2006 Sep 5.
We describe 46 Cryptococcus gattii-infected persons identified by population-based surveillance conducted in South Africa. Most patients with C. gattii infection presented with meningitis. The mortality rate during hospitalization was 36%. We found no significant differences between persons with and persons without C. gattii infection with regard to clinical presentation, acquired immunodeficiency syndrome diagnosis, concomitant conditions, or prior opportunistic infections. C. gattii isolates had low MICs to the tested antifungal drugs.
我们描述了在南非进行的基于人群监测中确定的46例感染加氏隐球菌的患者。大多数加氏隐球菌感染患者表现为脑膜炎。住院期间的死亡率为36%。我们发现,在临床表现、获得性免疫缺陷综合征诊断、伴随疾病或既往机会性感染方面,感染加氏隐球菌的人与未感染加氏隐球菌的人之间没有显著差异。加氏隐球菌分离株对所测试的抗真菌药物的最低抑菌浓度较低。